Effects of Vitamin B6 on Relieving Linezolid-associated Cytopenias

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-11001180

Enrollment

Unknown

Registered

2011-02-15

Start date

2010-11-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious disease

Interventions

Group A:Linezolid

Group B:Linezolid+vitamin B6

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Use of linezolid is not less than 3 days

Exclusion criteria

Exclusion criteria: Serious adverse reactions

Design outcomes

Primary

Measure	Time frame
PLT;RBC;Hb;HCT;	—

Countries

China

Contacts

Public ContactLixin Xie

xielx@263.net+86 10 55499130

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026